Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
Department of Neuropsychiatry, Okayama University Hospital.
Acta Med Okayama. 2021 Jun;75(3):315-322. doi: 10.18926/AMO/62226.
It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach's alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=-0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
在治疗精神分裂症时,评估功能障碍是必要的。世界卫生组织残疾评估表 2.0(WHODAS 2.0)已被《精神障碍诊断与统计手册》第五版采用为衡量功能障碍的标准。本研究是一项横断面研究的二次分析,该研究调查了精神分裂症患者的健康相关行为。我们检验了由患者自评的 12 项 WHODAS 2.0 日本版的有效性和可靠性。参与者为来自精神病院的 350 名门诊精神分裂症患者。WHODAS 2.0 的标准六因素结构在这些参与者中表现出良好的拟合度。Cronbach's alpha 系数为 0.858,表明内部一致性良好。WHODAS 2.0 与改良的全球功能评估和 Kessler 6 量表之间存在中度相关性(分别为 r=-0.434 和 0.555)。本研究结果表明,12 项自评 WHODAS 2.0 日本版在精神分裂症患者中具有良好的内部一致性和聚合效度。需要进一步探索 WHODAS 2.0 在临床环境中的有用性。